Ruffer LLP’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,504
| Closed | -$312K | – | 72 |
|
|
2023
Q1 | $312K | Sell |
4,504
-72,451
| -94% | -$5.02M | 0.01% | 85 |
|
|
2022
Q4 | $5.55M | Sell |
76,955
-262,276
| -77% | -$18.9M | 0.37% | 40 |
|
|
2022
Q3 | $23.8M | Sell |
339,231
-1,207,574
| -78% | -$84.8M | 1.49% | 23 |
|
|
2022
Q2 | $119M | Sell |
1,546,805
-1,761,973
| -53% | -$136M | 4.69% | 8 |
|
|
2022
Q1 | $242M | Sell |
3,308,778
-1,628,767
| -33% | -$119M | 5.65% | 6 |
|
|
2021
Q4 | $306M | Buy |
4,937,545
+988,450
| +25% | +$61.4M | 7.38% | 4 |
|
|
2021
Q3 | $234M | Sell |
3,949,095
-300,178
| -7% | -$17.8M | 7.4% | 3 |
|
|
2021
Q2 | $284M | Buy |
4,249,273
+52,417
| +1% | +$3.5M | 7.95% | 4 |
|
|
2021
Q1 | $265M | Buy |
4,196,856
+2,327,044
| +124% | +$147M | 8.11% | 4 |
|
|
2020
Q4 | $116M | Buy |
1,869,812
+1,617,638
| +641% | +$100M | 3.93% | 10 |
|
|
2020
Q3 | $15.2M | Sell |
252,174
-2,993
| -1% | -$180K | 0.71% | 26 |
|
|
2020
Q2 | $15.8M | Sell |
255,167
-475,735
| -65% | -$29.5M | 0.61% | 27 |
|
|
2020
Q1 | $40.7M | Sell |
730,902
-4,522,472
| -86% | -$252M | 1.85% | 16 |
|
|
2019
Q4 | $337M | Buy |
5,253,374
+5,135,274
| +4,348% | +$330M | 9.83% | 2 |
|
|
2019
Q3 | $5.99M | Sell |
118,100
-3,370
| -3% | -$171K | 0.17% | 39 |
|
|
2019
Q2 | $5.51M | Buy |
+121,470
| New | +$5.51M | 0.13% | 46 |
|